REVB - Balance Sheet - Revelation Biosciences, Inc.

Current Liabilities	1.91 M
Accounts Payable	784 K
Short-Term Debt	0
Other Current Liabilities	1.13 M
Non-Current Liabilities	0
Long-Term Debt	0
Other Non-Current Liabilities	0

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019
ASSETS
Cash & Cash Equivalents	6.5	12.0	5.3	1.3	4.5	0
Short Term Investments	0	0	0	0	0.5	0
Receivables	0	0	0	0	0	0
Inventory	0	0	0	0	0	0
Other Current Assets	49.5 K	0.2	0.2	0.6	0.1	0
Total Current Assets	6.6	12.1	5.4	1.9	4.6	0
PP&E	56.3 K	65.1 K	90.1 K	0.1	0	0
Intangible Assets	0	0	0	0	0	0
Goodwill	0	0	0	0	0	0
Long Term Investments	0	0	0	0	73.5	0
Other Long Term Assets	0	0	0	0	0	22.7 K
Other Assets	0	0	0	0	(73.5)	0
Total Assets	6.6	12.2	5.5	2.0	4.6	22.7 K
LIABILITIES
Accounts Payable	0.8	1.4	0.6	0.6	0.9	0
Short Term Debt	0	0	0	16.8 K	0	0
Other Current Liabilities	1.1	4.2	3.9	1.5	0.3	26.3 K
Total Current Liabilities	1.9	5.6	4.5	2.1	1.2	26.3 K
Long Term Debt	0	0	0	0	0	0
Deferred Tax Income	0	0	0	0	0	0
Other Liabilities	0	0	0	0	0	0
Total Liabilities	1.9	5.6	4.5	2.1	1.2	26.3 K
EQUITY
Common Stock	522	265	683	2.31 K	2.29 K	0
Retained Earnings	(40 505.6)	(25.5)	(25.3)	(14.5)	(2.5)	3.64 K
Other Accumulative Comprehensive Income/Loss	0	0	0	0	0	0
Total Equity	4 708.4	6.6	1.1	99.5 K	3.4	3.64 K
Total Liabilities and Equity	6.6	12.2	5.5	2.0	4.6	22.7 K
SHARES OUTSTANDING
Common Shares Outstanding	1.7	0.2	18 K	9.4 K	8.66 K	8.66 K

Free